GALECTIN THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.34 USD | -0.89% |
|
-3.19% | +101.20% |
Chart calendar Galectin Therapeutics Inc.
f.4Ad8oY7s5JM1MHR8b6w-3iJcCrSk2xMASr3Dg6ZLkaE.pX4M7L6YyeVWeitFHsd0jFcJSY3MjVU3DdGpzpcq_sSTUQjx3dy76m1FFw~586d54e6f253b1d5e8d0e519d955672e
Upcoming events on Galectin Therapeutics Inc.
Past events on Galectin Therapeutics Inc.
| 2024-03-29 08:00 am | Q4 2023 Earnings Release |
| 2023-12-07 11:00 am | Annual General Meeting |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-11-12 08:00 am | American Association for the Study of Liver Diseases Conference - Abstract Number : 3130-A |
| 2023-11-12 08:00 am | American Association for the Study of Liver Diseases Conference - Abstract Number : 3079-A |
| 2023-11-11 08:00 am | American Association for the Study of Liver Diseases Conference - Abstract Number : 2103-A |
| 2023-11-11 08:00 am | American Association for the Study of Liver Diseases Conference - Abstract Number : 2269-C |
| 2023-11-11 08:00 am | American Association for the Study of Liver Diseases Conference - Abstract Number : 2450-C |
| 2023-10-24 11:30 am | H.C. Wainwright NASH Investor Conference |
| 2023-09-27 02:25 pm | Discovery on Target Meeting |
| 2023-09-13 12:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-06 | Paris NASH Meeting |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-05-02 10:30 am | H.C. Wainwright BioConnect Investor Conference |
| 2023-03-24 | American Association for the Study of Liver Diseases Conference |
| 2022-12-01 11:00 am | Annual General Meeting |
| 2022-11-29 | Obesity and NASH Drug Development Summit |
| 2022-11-14 08:00 am | Q3 2022 Earnings Release |
| 2022-10-19 | Discovery on Target Conference |
| 2022-10-17 12:00 pm | H.C. Wainwright NASH Investor Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -13,4 -11,8 -14.37% | -23,4 -24,6 4.75% | -30,2 -34,0 11.12% | -38,4 -38,0 -1.01% | -38,1 -38,2 0.36% | -41,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,3 -11,6 -14.63% | -23,5 -24,5 4.37% | -30,5 -34,7 12.08% | -38,8 -38,3 -1.3% | -41,1 -40,7 -1.01% | -40,7 |
|
Net income Million USD | Released Forecast Spread | -20,2 -15,0 -34.46% | -23,6 -24,6 4.1% | -30,7 -34,9 12.02% | -38,9 -38,4 -1.3% | -44,8 -44,4 -0.92% | -41,0 |
|
EPS USD | Released Forecast Spread | -0,39 -0,35 -11.43% | -0,41 -0,43 4.65% | -0,52 -0,59 11.86% | -0,65 -0,65 0% | -0,74 -0,74 0% | -0,66 |
| Announcement Date | 16/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,43 -11,2 33.71% | -9,94 -8,10 -22.65% | -9,66 -11,0 12.16% | -8,12 -12,0 32.32% | -10,6 -10,3 -3.74% | -10,3 -12,5 17.26% | -9,00 -12,5 27.98% | -9,17 -9,50 3.52% | -9,56 -9,70 1.43% | -10,1 | -10,1 | -10,5 | -10,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,22 -11,4 36.74% | -9,93 -8,38 -18.59% | -9,61 -11,3 14.74% | -8,60 -11,9 27.67% | -10,6 -10,1 -4.92% | -11,5 -12,4 6.85% | -9,11 -12,4 26.35% | -10,4 -9,39 -11.11% | -10,00 -9,59 -4.3% | -9,98 | -9,98 | -10,4 | -10,4 |
|
Net income Million USD | Released Forecast Spread | -7,29 -11,5 36.52% | -9,92 -8,38 -18.37% | -9,68 -11,3 14.66% | -8,58 -11,9 27.81% | -10,7 -10,2 -4.89% | -11,5 -12,4 6.87% | -9,18 -12,4 26.23% | -14,0 -9,39 -49.58% | -10,1 -9,65 -4.25% | -10,0 | -10,0 | -10,5 | -10,5 |
|
EPS USD | Released Forecast Spread | -0,12 -0,19 36.84% | -0,17 -0,14 -21.43% | -0,16 -0,19 15.79% | -0,14 -0,20 30% | -0,18 -0,17 -5.88% | -0,19 -0,21 9.52% | -0,15 -0,21 28.57% | -0,24 -0,16 -50% | -0,16 -0,16 0% | -0,16 | -0,16 | -0,17 | -0,17 |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | - | - | - | - |
| 2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 01:00 am | VALNEVA: Q1 2024 Earnings Release |
| 2024-05-07 07:00 am | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Galectin Therapeutics Inc.
| 2024-05-02 04:10 pm | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 am | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GALT Stock
- Calendar Galectin Therapeutics Inc.
